Kim Jae B. 4
4 · Avidity Biosciences, Inc. · Filed Feb 4, 2021
Insider Transaction Report
Form 4
Kim Jae B.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-02+82,000→ 82,000 totalExercise: $22.34Exp: 2031-02-01→ Common Stock (82,000 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 1, 2021 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.